Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases

被引:0
|
作者
Kirti Raj Bhatele
Anand Jha
Kavish Kapoor
Devanshu Tiwari
机构
[1] RJIT,
[2] BSF Academy,undefined
[3] Kavlabs,undefined
[4] RGPV,undefined
来源
Cognitive Neurodynamics | 2022年 / 16卷
关键词
Neurodegenerative diseases; Parkinson; Alzheimer; Capsule network; ResNet50; VGG 16; VGG 19; InceptionV3 etc.;
D O I
暂无
中图分类号
学科分类号
摘要
The two most generally diagnosed Neurodegenerative diseases are the Alzheimer and Parkinson diseases. So this paper presents a fully automated early screening system based on the Capsule network for the classification of these two Neurodegenerative diseases. In this study, we hypothesized that the Neurodegenerative diseases-Caps system based on the Capsule network architecture accurately performs the multiclass i.e. three class classification into either the Alzheimer class or Parkinson class or Healthy control and delivers better results in comparison other deep transfer learning models. The real motivation behind choosing the capsule network architecture is its more resilient nature towards the affine transformations as well as rotational & translational invariance, which commonly persists in the medical image datasets. Apart from this, the capsule networks overcomes the pooling layers related deficiencies from which conventional CNNs are mostly affected and unable to delivers accurate results especially in the tasks related to image classification. The various Computer aided systems based on machine learning for the classification of brain tumors and other types of cancers are already available. Whereas for the classification of Neurodegenerative diseases, the amount of research done is very limited and the number of persons suffering from this type of diseases are increasing especially in developing countries like India, China etc. So there is a need to develop an early screening system for the correct multiclass classification into Alzheimer’s, Parkinson’s and Normal or Healthy control cases. The Alzheimer disease and Parkinson progression (ADPP) dataset is used in this research study for the training of the proposed Neurodegenerative diseases-Caps system. This ADPP dataset is developed with the aid of both the Parkinson's Progression Markers Initiative (PPMI) and Alzheimer’s disease Neuroimaging Initiative (ADNI) databases. There is no such early screening system exist yet, which can perform the accurate classification of these two Neurodegenerative diseases. For the sake of genuine comparison, other popular deep transfer learning models like VGG19, VGG16, ResNet50 and InceptionV3 are implemented and also trained over the same ADPP dataset. The proposed Neurodegenerative diseases-Caps system deliver accuracies of 97.81, 98, 96.81% for the Alzheimer, Parkinson and Healthy control or Normal cases with 70/30 (training/validation split) and performs way better as compare to the other popular Deep transfer learning models.
引用
收藏
页码:1361 / 1377
页数:16
相关论文
共 50 条
  • [1] Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases
    Bhatele, Kirti Raj
    Jha, Anand
    Kapoor, Kavish
    Tiwari, Devanshu
    COGNITIVE NEURODYNAMICS, 2022, 16 (06) : 1361 - 1377
  • [2] Classification of Neurodegenerative Diseases Based on CNN and LSTM
    Li, Lanjuan
    Ning, Zubiao
    Jin, Xinyu
    2018 NINTH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY IN MEDICINE AND EDUCATION (ITME 2018), 2018, : 82 - 85
  • [3] Brain Pattern Recognition Based Classification of Neurodegenerative Diseases
    Happila, T.
    Stanley, Kingston P.
    2015 INTERNATIONAL CONFERENCE ON INNOVATIONS IN INFORMATION, EMBEDDED AND COMMUNICATION SYSTEMS (ICIIECS), 2015,
  • [4] Spatially informed Bayesian neural network for neurodegenerative diseases classification
    Payares-Garcia, David
    Mateu, Jorge
    Schick, Wiebke
    STATISTICS IN MEDICINE, 2023, 42 (02) : 105 - 121
  • [5] The Future of Cognitive Screening in Neurodegenerative Diseases
    Umfleet, Laura Glass
    Bilder, Robert M.
    Loring, David W.
    Thames, April
    Hampstead, Benjamin M.
    Bauer, Russell M.
    Drane, Daniel L.
    Cavanagh, Lucia
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 93 (01) : 47 - 59
  • [7] The complement system in neurodegenerative diseases
    Nimmo, Jacqui
    Byrne, Robert A. J.
    Daskoulidou, Nikoleta
    Watkins, Lewis M.
    Carpanini, Sarah M.
    Zelek, Wioleta M.
    Morgan, B. Paul
    CLINICAL SCIENCE, 2024, 138 (06) : 387 - 412
  • [8] High Content Screening in Neurodegenerative Diseases
    Jain, Shushant
    van Kesteren, Ronald E.
    Heutink, Peter
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (59):
  • [9] Orexinergic System in Neurodegenerative Diseases
    Wang, Qinqin
    Cao, Fei
    Wu, Yili
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [10] Construction trials for PPI-based drug screening system on neurodegenerative diseases
    Oshikane, Hiroyuki
    Arisaka, Fumio
    Watabe, Masahiko
    Aoyama, Koji
    Nakaki, Toshio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S156 - S156